Escaping Host Factor PI4KB Inhibition: Enterovirus Genomic RNA Replication in the Absence of Replication Organelles by Melia, C.E. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/182484
 
 
 
Please be advised that this information was generated on 2018-04-11 and may be subject to
change.
Article
Escaping Host Factor PI4KB Inhibition: Enterovirus
Genomic RNA Replication in the Absence of
Replication Organelles
Graphical Abstract
Highlights
d PI4KB activity expedites the formation of coxsackievirus
replication organelles (ROs)
d PI4KB inhibition impairs polyprotein processing, which is
rescued by a 3A mutation
d Upon PI4KB inhibition, this mutant replicates at the Golgi in
the absence of ROs
d Innate immune responses are not enhanced when RO
biogenesis is delayed
Authors
Charlotte E. Melia,
Hilde M. van der Schaar,
Heyrhyoung Lyoo, ..., Abraham J. Koster,
Montserrat Ba´rcena,
Frank J.M. van Kuppeveld
Correspondence
m.barcena@lumc.nl (M.B.),
f.j.m.vankuppeveld@uu.nl (F.J.M.v.K.)
In Brief
Like other positive-strand RNA viruses,
enteroviruses reorganize host
endomembranes for genome replication.
Melia et al. demonstrate a pivotal role of
PI4KB activity both in the rapid
biogenesis of coxsackievirus replication
organelles and in polyprotein processing.
The notion that membrane
rearrangements are indispensable for
genome replication and innate immune
evasion is challenged.
Melia et al., 2017, Cell Reports 21, 587–599
October 17, 2017 ª 2017 The Authors.
https://doi.org/10.1016/j.celrep.2017.09.068
Cell Reports
Article
Escaping Host Factor PI4KB Inhibition: Enterovirus
Genomic RNA Replication in the Absence
of Replication Organelles
Charlotte E. Melia,1,5 Hilde M. van der Schaar,2,5 Heyrhyoung Lyoo,2 Ronald W.A.L. Limpens,1 Qian Feng,2,6
Maryam Wahedi,2 Gijs J. Overheul,3 Ronald P. van Rij,3 Eric J. Snijder,4 Abraham J. Koster,1 Montserrat Ba´rcena,1,7,*
and Frank J.M. van Kuppeveld2,7,8,*
1Department of Molecular Cell Biology, Leiden University Medical Center, Leiden 2333 ZC, the Netherlands
2Department of Infectious Diseases & Immunology, Utrecht University, Utrecht 3584 CL, the Netherlands
3Department of Medical Microbiology, Radboud Institute for Molecular Life Sciences, Nijmegen 6525 GA, the Netherlands
4Department of Medical Microbiology, Leiden University Medical Center, Leiden 2333 ZA, the Netherlands
5These authors contributed equally
6Present address: Institute of Biochemistry, ETH Z€urich, 8093 Z€urich, Switzerland
7These authors contributed equally
8Lead Contact
*Correspondence: m.barcena@lumc.nl (M.B.), f.j.m.vankuppeveld@uu.nl (F.J.M.v.K.)
https://doi.org/10.1016/j.celrep.2017.09.068
SUMMARY
Enteroviruses reorganize cellular endomembranes
into replication organelles (ROs) for genome replica-
tion. Although enterovirus replication depends on
phosphatidylinositol 4-kinase type IIIb (PI4KB), its
role, and that of its product, phosphatidylinositol
4-phosphate (PI4P), is only partially understood.
Exploiting a mutant coxsackievirus resistant to
PI4KB inhibition, we show that PI4KB activity has
distinct functions both in proteolytic processing
of the viral polyprotein and in RO biogenesis. The
escape mutation rectifies a proteolytic processing
defect imposed by PI4KB inhibition, pointing to
a possible escape mechanism. Remarkably, under
PI4KB inhibition, the mutant virus could replicate its
genome in the absence of ROs, using instead the
Golgi apparatus. This impaired RO biogenesis pro-
vided an opportunity to investigate the proposed
role of ROs in shielding enteroviral RNA from cellular
sensors. Neither accelerated sensing of viral RNA nor
enhanced innate immune responses was observed.
Together, our findings challenge the notion that
ROs are indispensable for enterovirus genome repli-
cation and immune evasion.
INTRODUCTION
Positive-strand RNA (+RNA) viruses comprise many human
pathogens, such as hepatitis C virus, Zika virus, dengue virus,
severe acute respiratory syndrome (SARS) and Middle East
respiratory syndrome (MERS) coronaviruses, and enteroviruses.
Despite substantial genetic divergence across virus families,
some features of replication are common to all +RNA viruses in-
fecting eukaryotes. One of the most striking is the remodeling
of host cell endomembranes into novel membranous compart-
ments in the cytoplasm of the infected cell. These compartments
serve as compositionally unique platforms upon which the com-
ponents of the viral RNA (vRNA) synthesis machinery assemble,
and whose micro-environments may facilitate efficient genome
replication (Romero-Brey and Bartenschlager, 2014; Paul and
Bartenschlager, 2013). In addition, they have been postulated
to play a role in the evasion of the innate antiviral host responses
by shielding vRNA products from cytosolic sensors such as
MDA5 and RIG-I, which signal to activate the type I interferon
(IFN-a/b) pathway, and protein kinase R (PKR), which activates
an integral stress response (Schulz and Mossman, 2016; White
and Lloyd, 2012).
Members of the Enterovirus genus, belonging to the Picorna-
viridae family, include poliovirus, coxsackie A and B viruses,
several numbered enteroviruses (e.g., EV-D68, EV-A71), and
rhinoviruses, which are causative agents of various human dis-
eases. Enteroviruses, like other positive-sense RNA viruses,
modify host-cell membranes to form structures with novel mor-
phologies. These modified membranes serve as platforms for
viral replication, which we will refer to as replication organelles
(ROs). At earlier stages of coxsackievirus B3 (CVB3) or poliovirus
(PV) infection, ROs emerge as single-membrane tubules that
appear to form at the expense of the Golgi apparatus. These tu-
bules are interspersed with double-membrane vesicles (DMVs),
which are believed to arise as tubules deform and enwrap small
volumes of cytosol. In this way, most tubules transform into
DMVs over the course of infection, and DMVs may be further
enwrapped to form multilamellar vesicles (Limpens et al., 2011;
Belov et al., 2012). Each stage of virus replication, including
the transformation of cellular membranes into ROs, is dependent
upon the interplay between viral proteins and host factors. The
small, membrane-anchored enterovirus 3A protein has a key
role in generating ROs (Suhy et al., 2000) and is known to recruit
host factors that are essential for genome replication. One of
these factors is phosphatidylinositol 4-kinase type IIIb (PI4KB)
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(Hsu et al., 2010; van der Schaar et al., 2013). In uninfected cells,
PI4KB is a Golgi-resident enzyme that generates phosphatidyli-
nositol 4-phosphate (PI4P), while during enterovirus infection the
viral 3A protein recruits PI4KB to ROs, enriching them in PI4P
(Hsu et al., 2010; Greninger et al., 2012).
The importance of PI4P in viral infections has been the subject
of several recent investigations, both for the Picornaviridae, such
as Aichivirus (genus Kobuviruses) and encephalomyocarditis
virus (EMCV) (genus Cardiovirus), and for other +RNA viruses,
such as hepatitis C virus (HCV) (Altan-Bonnet and Balla, 2012;
Dorobantu et al., 2015). In uninfected cells, PI4P is involved
in a multitude of functions, including signaling, membrane traf-
ficking, regulation of Golgi apparatus organization, and lipid
homeostasis (Clayton et al., 2013; De Matteis et al., 2013). Of
particular relevance for viruses that utilize PI4P is the exchange
of PI4P and cholesterol between the Golgi apparatus and endo-
plasmic reticulum (ER), which is mediated by the oxysterol-bind-
ing protein (OSBP). OSBP acts as a bridge between these two
membrane compartments to generate a membrane contact
site, using PI4P as a Golgi-based anchor and vesicle-associated
membrane protein-associated protein A (VAP-A) as an ER an-
chor (Mesmin et al., 2013). During enterovirus infection, OSBP
is diverted to create a novel type of membrane contact site
between ROs and the ER. These sites mediate the exchange
of PI4P for cholesterol, which is another essential lipid for entero-
virus genome replication (Arita, 2014; Strating et al., 2015; Roulin
et al., 2014).
Recruitment of PI4KB by the viral 3A protein is critical for
enterovirus genome replication (Hsu et al., 2010; van der Schaar
et al., 2013), but its exact role is unclear. The stage of genome
replication in the enterovirus life cycle encompasses different
processes, including proteolytic processing of the polyprotein,
RO biogenesis, and RNA synthesis by the viral replication
machinery. In this study, we used a CVB3 mutant resistant to
PI4KB inhibition, CVB3 3A-H57Y (van der Schaar et al., 2012),
to further dissect the role of PI4KB and the PI4P-rich environ-
ment it generates during genome replication. We show that
PI4KB activity facilitates efficient proteolytic processing of the
CVB3 polyprotein. The 3A-H57Y substitution compensates
for the impairment of polyprotein processing caused by PI4KB
inhibition, which may represent the escape mechanism of this
mutant virus. Distinct from its effect on polyprotein processing,
we found that PI4KB inhibition also delayed RO formation.
Remarkably, CVB3 3A-H57Y could replicate its genome in the
absence of detectable ROs when PI4KB was inhibited. Under
these conditions, vRNA synthesis was observed instead at a
cellular organelle, the Golgi apparatus, which challenges the
notion that ROs are essential for the exponential phase of
genome replication. Golgi disintegration and RO formation did
eventually occur under PI4KB inhibition, which suggests that
PI4KB activity is not fundamentally required for RO biogenesis,
but expedites the process. The delay in RO formation under
PI4KB inhibition was exploited to experimentally test the hypoth-
esis that ROs shield vRNA from cytoplasmic sensors of the
innate immune system. Our results suggest that in addition to
being dispensable for vRNA synthesis, enterovirus ROs do not
play a pivotal role in suppression of the innate antiviral response
pathways.
RESULTS
CVB3 3A-H57Y RO Formation Is Impaired under PI4KB
Inhibition
First, we set out to study the morphology of the ROs induced
by CVB3 3A-H57Y under conditions where PI4KB is not in-
hibited. Infected BGM cells were prepared for electron micro-
scopy (EM) by high-pressure freezing and freeze substitution at
different times post-infection and analyzed for the presence of
membrane modifications. The first ROs induced by CVB3
3A-H57Y were detected at 5 hr post-infection (hpi). At this stage,
single-membrane tubules were predominant, interspersed with
DMVs (Figure 1A). The emergence of ROs coincides with disinte-
gration of the Golgi apparatus in wild-type (WT) infection
(Limpens et al., 2011) and, concordantly, the Golgi apparatus
was not observed in cell sections that contained ROs at any
time point in this analysis. Later in infection, tubules had largely
transformed into DMVs (Figure 1A, 6 hpi) andmultilamellar struc-
tures (Figure 1A, 7 hpi). This progression closely reflects obser-
vations of WT CVB3 RO development with regard to both the
specific morphologies induced and the time frame over which
they develop (Limpens et al., 2011) (Figure S1A). Together, these
results indicate that the 3A-H57Y substitution does not affect RO
development or their general architecture.
Next, we investigated the effect of PI4KB inhibition on RO
development during CVB3 3A-H57Y infection. To determine suit-
able time points for EM analysis of cells infected in the presence
of aPI4KB inhibitor,we firstmeasured viral replication in thepres-
ence of BF738735, a potent and specific PI4KB inhibitor without
overt cytotoxicity (also known as compound 1; van der Schaar
et al., 2013; MacLeod et al., 2013). Unlike CVB3WT (Figure S2A),
CVB3 3A-H57Y was resistant to BF738735 (Figure S2B),
although its replication was nevertheless delayed and impaired
in the presence of BF738735with regard to both vRNA and infec-
tious progeny virus. This is in agreement with observations using
other PI4KB inhibitors (e.g., PIK93; van der Schaar et al., 2012).
To examine whether the impairment of replication upon PI4KB
inhibition was the consequence of a decrease in the number of
infected cells and/or a reduced level of vRNA replication, we
collected cells infected with EGFP-CVB3 3A-H57Y at different
time points post-infection and analyzed them with flow cytome-
try. PI4KB inhibition reduced the number of CVB3 3A-H57Y-in-
fected cells (by 3-fold), delayed replication (by 1–2 hr), and
limited viral protein production, as reflected by reduced EGFP
levels (Figure S2C). These results indicate that thePI4KB inhibitor
imposes a critical barrier to CVB3 3A-H57Y replication in a sub-
population of cells and reduces the efficiency of replication in
those cells where infection is established.
Based on the growth curve analysis, cells were fixed and pro-
cessed for EM between 5 and 8 hpi, as this period encompasses
the exponential phase of vRNA replication for CVB3 3A-H57Y
under PI4KB inhibition. Remarkably, while ROs were detected
at a frequency of 50% in EM cell sections from infections in
the absence of PI4KB inhibitor (n = 43 cell sections assessed
at 6 hpi), neither archetypal enterovirus ROs (i.e., clusters of sin-
gle-membrane tubules and/or DMVs) nor cellular membranes
with atypical morphologies were detected in cells infected under
PI4KB inhibition (n = 153 cell sections), even at late time points
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(7–8 hpi, n = 47 cell sections, example shown in Figure 1B).
Seemingly intact Golgi cisternae were apparent in these cells
and detected at a frequency similar to that of mock-infected or
BF738735-treated cells (Figures S1B and S1C, respectively).
Corresponding immunofluorescence microscopy data showed
a high percentage of cells positive for double-stranded RNA
(dsRNA) labeling, confirming that the lack of membrane modifi-
cations in the EM analysis was not simply due to a low number
of infected cells (Figure 1B, right). These data show that RO
development is impaired by PI4KB inhibition and suggest that
replication may be taking place instead at a cellular organelle.
CVB3 3A-H57Y Replicates Its Genome at the Golgi
Apparatus under PI4KB Inhibition
As an initial indicator of the replication site under PI4KB inhibi-
tion, we performed immunofluorescence microscopy on in-
fected cells (Figure 2A). Cells were fixed at 5 hpi in the absence
of inhibitor and at 6 hpi in the presence of inhibitor given the delay
A
B
Figure 1. CVB3 3A-H57Y RO Formation Is
Impaired under PI4KB Inhibition
BGM cells infected with CVB3 3A-H57Y (MOI 50).
(A) Cells fixed for EM analysis at early (5 hpi), in-
termediate (6 hpi), or late (7 hpi) stages of infection
show the progression in RO development.
(B) ROs were not observed in EM cell sections (up
to 8 hpi, n = 153) from cells treated with BF738735.
An example of the Golgi apparatus in cells fixed at
7 hpi (left). Parallel immunofluorescence data
(right) (dsRNA, green; nuclear stain, blue).
Scale bars represent 1 mm. See also Figures S1
and S2.
in replication. Similar to findings for WT
virus (Hsu et al., 2010; van der Schaar
et al., 2012), both 3A and dsRNA were
detected throughout the cytoplasm in
cells infected with CVB3 3A-H57Y in the
absence of PI4KB inhibition (Figure 2A,
left panels). Golgi disassembly could
be readily visualized through the signal
reduction and dispersion of the cis-Golgi
marker GM130 and the trans-Golgi
network marker TGN46, whereas the
PI4KB signal overlapped with the 3A la-
beling. Upon PI4KB inhibitor treatment,
however, 3A and dsRNA were primarily
confined to the perinuclear region (Fig-
ure 2A, right panels). In wide-field images,
the strength and distribution of GM130
and TGN46 signals were largely main-
tained and overlapped with the viral 3A
signal. These results suggested that
both the 3A-H57Y protein and dsRNA
reside at the Golgi apparatus in the pres-
ence of the inhibitor. To confirm that
these observations were due to specific
inhibition of PI4KB, the localization of
3A-GFP was assessed using different
PI4KB inhibitors. Similar to BF738735, enviroxime, GW5074, or
PIK93 treatment resulted the accumulation of 3A specifically at
the Golgi region, although confocal imaging revealed that 3A
did not directly co-localize with the cis-Golgi marker GM130
(Figure 2B).
To unambiguously determine the subcellular location of the
3A-H57Y protein under PI4KB inhibitor treatment, correlative
light and EM (CLEM) was performed. For this, we employed
the split-GFP system (Cabantous et al., 2005) to label the 3A-
H57Y protein, using an approach similar to that previously re-
ported for WT CVB3 (van der Schaar et al., 2016b). To produce
a split-GFP CVB3 3A-H57Y mutant, the final beta sheet of GFP
(i.e., strand 11), further referred to as GFP(S11), was introduced
into the 3A-H57Y protein to produce CVB3 3A-H57Y(S11). Upon
CVB3 3A-H57Y(S11) infection of BGM cells stably expressing
the remaining portion of GFP (GFPS1-10), the two fragments
of GFP self-assemble to produce GFP-tagged 3A-H57Y. GFP-
tagged 3A-H57Y was then visualized by confocal microscopy
Cell Reports 21, 587–599, October 17, 2017 589
before chemical fixation and processing for EM. Overlays of 3A-
H57Y-GFP signal with the corresponding EM cell sections fixed
at 6 hpi revealed that the 3A protein localized specifically to the
Golgi apparatus (Figure 3A).
The presence of the 3A-H57Y protein at the Golgi apparatus
suggested that vRNA replication occurs at this compartment un-
der PI4KB inhibition. To further investigate this, metabolic label-
ing was performed to detect newly synthesized vRNA in situ.
A
B
Figure 2. The 3A Protein Localizes to the Golgi Apparatus under PI4KB Inhibition
BGM cells infected with CVB3 3A-H57Y (MOI 10).
(A) Untreated cells were fixed at 5 hpi (left panels), and drug-treated cells were fixed at 6 hpi (right panels).
(B) Cells were treated with different PI4KB inhibitors and fixed at 6 hpi.
Fixed cells were labeled with the indicated antibodies and a nuclear stain (blue). Scale bars represent 10 mm.
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Infected cells were pretreated with 10 mg/mL dactinomycin to
inhibit cellular transcription and incubated with tritiated uridine
for 45 min prior to fixation to label newly synthesized vRNA. As
a control, mock-infected cells underwent the same treatment.
After processing for EM, radiolabelled uridine was detected by
autoradiography. In cells infected with CVB3 3A-H57Y without
PI4KB inhibition, abundant autoradiography signal was found
in regions containing typical ROs (Figure 3B). Although ROmem-
branes in chemically fixed samples appeared somewhat dis-
tended in comparison to high-pressure frozenmaterial (Figure 1),
they were recognizable as clusters of single-membrane com-
partments (Figure 3B, black arrowhead) interspersed with
DMVs (Figure 3B, white arrowhead) that closely resemble the
ROs observed in chemically fixed PV-infected (Dales et al.,
1965; Belov et al., 2012) or WT-CVB3-infected cells (van der
Schaar et al., 2016b). In CVB3-3A-H57Y-infected cells treated
with PI4KB inhibitor and fixed at 7 hpi, ROs were not observed
(n = 148 cell sections), and abundant autoradiography signal
was found at the Golgi apparatus (Figure 3C), with the vast
majority of signal localizing to the trans side of the Golgi
apparatus and trans-Golgi network rather than the Golgi
cisternae. This demonstrates that under PI4KB inhibition,
B C
A Figure 3. Replication under PI4KB Inhibi-
tion Occurs at the Golgi Apparatus
(A) BGM(GFPS1-10) cells infected with CVB3
3A-H57Y(S11) (MOI 7) monitored by live-cell LM,
fixed at 6 hpi, and processed for CLEM. Overlay of
the 3A-GFP signal at the time of fixation with the
corresponding EM image (left). Inset highlights one
of two 3A-GFP foci present in the image shown,
both of which correspond to Golgi membranes.
Scale bars represent 2 mm.
(B and C) BGM cells infected with CVB3 3A-H57Y
(MOI 50), metabolically labeled, fixed at 6 hpi (B) or
7 hpi (C), and processed for EM autoradiography
to detect newly synthesized vRNA. The autoradi-
ography signal is apparent as electron-dense
grains. (B) ROs positive for ARG signal were
readily observed in the absence of BF738735.
(C) In cells treated with BF738735, ROs were not
observed, and clusters of autoradiography signal
were found exclusively at the Golgi apparatus. cis,
Golgi apparatus cis face; trans, Golgi apparatus
trans face; TGN, trans-Golgi network. Scale bars
represent 1 mm.
CVB3 3A-H57Y can replicate its genome
in the absence of ROs on a seemingly
intact Golgi apparatus.
Under PI4KB Inhibition, ROs Form
Late in CVB3-3A-H57Y-Infected
Cells
Our results thus far show that under
PI4KB inhibition, CVB3 3A-H57Y replica-
tion is possible in association with an
apparently intact cellular organelle. We
next set out to establish whether PI4KB
inhibition precludes Golgi disintegration
and RO development entirely or simply delays the process.
Confocal microscopy of live cells expressing mCherry-GM130
was performed to monitor the Golgi apparatus across the
course of CVB3 3A-H57Y(S11) infection, either with or without
BF738735 treatment (Figures 4A–4C). In the absence of inhibi-
tor, the process of Golgi fragmentation following CVB3 3A-
H57Y(S11) infection was similar to that of WT split-GFP CVB3
infections (van der Schaar et al., 2016b). The onset of Golgi frag-
mentation occurred in conjunction with or even preceded 3A
protein accumulation in the Golgi area, and Golgi disintegration
was typically complete within 25 min (n = 23 cells) (Figures 4A
and 4C, top graph). In the absence of PI4KB inhibition, the early
3A signal was often located at peripheral foci (Figure 4A arrow-
heads), and under PI4KB inhibition, the first 3A signal was often
found in the Golgi region (Figure 4B, arrowheads). Remarkably,
the Golgi apparatus of most CVB3-3A-H57Y(S11)-infected cells
did disassemble during infections under PI4KB inhibition, but
withmarkedly different dynamics. The onset of disintegration un-
der these conditions did not coincide with 3A protein accumula-
tion at the Golgi but suffered a relative average delay of 30 min
(n = 48 cells). Additionally, the time needed for Golgi disintegra-
tion was highly variable under PI4KB inhibition. In a minority of
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infected cells treated with BF738735, Golgi disassembly was
as rapid as in untreated cells. However, in most cells, the Golgi
disintegration process was substantially prolonged (by up to
10 hr) under PI4KB inhibition (Figures 4B and 4C, bottom graph).
To determine whether Golgi disassembly under PI4KB inhibi-
tion was associated with the development of ROs, CLEM was
performed on cells infected with split-GFP 3A-H57Y(S11) virus
under BF738735 treatment and fixed at 9 hpi. While some cells
retained seemingly intact Golgi membranes at this late stage in
infection, in those cells lacking recognizable Golgi membranes,
the 3A-GFP signal was found at structures resembling typical
early ROs (Figure 4D; see Figure 3A for comparison). As verified
A B
D
C
Figure 4. Golgi Disintegration during CVB3
3A-H57Y Infection Is Prolonged under
PI4KB Inhibition and Ultimately Results in
RO Formation
(A–D) BGM(GFPS1-10) cells transduced with
MLV mCherry-GM130, infected with CVB3 3A-
H57Y(S11) (MOI 7), and imaged by live-cell
confocal microscopy in the absence (A) or pres-
ence (B and D) of BF738735. Asterisks in (A) and
(B) denote completion of Golgi disintegration,
as evidenced by an entirely punctate mCherry-
GM130 signal. Initial 3A-GFP signal was detected
primarily at peripheral locations (A, arrowhead),
and Golgi disintegration was typically complete
within 25 min of its onset (C, top graph; n = 23
cells). In cells treated with BF738735, initial 3A-
GFP signal was detected primarily at the Golgi
apparatus (B, arrowhead). The Golgi disintegration
duration was typically prolonged but highly vari-
able (C, bottom graph; n = 48 cells). Cells were
fixed for EM analysis at 9 hpi (D). The LM-EM
overlay reveals single-membrane (black arrow-
head) and double-membrane (white arrowhead)
structures positive for 3A-GFP signal; scale bars
represent 5 mm. See also Figure S3.
by immunofluorescence microscopy,
PI4P did not accumulate in cells infected
under PI4KB inhibition (Figure S3), sug-
gesting that the ROs that develop during
CVB3 3A-H57Y infection under PI4KB
inhibition do so independently of high
PI4P levels.
PI4KB Activity Drives Rapid Golgi
Disassembly and RO Formation
RO formation is likely associated with the
amount of viral protein produced in the
cell, which in turn depends upon vRNA
replication levels. Therefore, rather than
the absence of high PI4P levels, the delay
in CVB3 3A-H57Y vRNA replication under
PI4KB inhibition could be solely respon-
sible for impeding RO formation. Previ-
ously, it was shown that replication-inde-
pendent expression of PV non-structural
proteins results in membranous struc-
tures reminiscent of ROs produced upon infection (Belov et al.,
2008). Here, we engineered a replication-independent CVB3
expression system, which produces high amounts of viral pro-
teins in the absence of vRNA replication. Hence, the inhibition
of vRNA replication caused by PI4KB inhibition will not result in
a delay in viral protein production in this setup. The system uti-
lizes a CVB3 cDNA placed under the control of the bacterio-
phage T7 RNA polymerase and is rendered replication incompe-
tent through modifications to the cloverleaf structure in the
50 UTR of the viral genome that prevent replication via the
CVB3 polymerase (Langereis et al., 2014). The 3A-H57Y substi-
tution was introduced into this replication-incompetent CVB3
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cDNA. Transfection of the CVB3 3A-H57Y cDNA plasmid in
HuH-7/T7 cells, which stably express the T7 RNA polymerase,
resulted in the expression of individual viral proteins whose
amounts were not affected by the addition of PI4KB inhibitor
(Figure S4). Immunofluorescence analysis of transfected cells
showed that the first 3A signal could be detected as early as
3 hr post-transfection (hpt), but without significant effects on
the Golgi apparatus. In the absence of PI4KB inhibitor, Golgi
disintegration was observed from 4 hpt onward, as evidenced
by the change in GM130 signal in transfected cells (Figure 5A,
top panels). Under PI4KB inhibition, Golgi disintegration was de-
layed by 1 hr (Figure 5A, middle and bottom panels). While
Golgi disintegration is more rapid in the replication-independent
system than during infection (see Figure 4), most likely because
of the high protein expression levels generated with this system,
these data nevertheless demonstrate that in cells with equal
levels of viral proteins, PI4KB inhibition delays enterovirus-
induced Golgi apparatus disassembly.
To determine the contribution of the 3A-H57Y substitution
to (delayed) Golgi disassembly, we examined whether the WT
CVB3 cDNA could also induce Golgi disassembly under PI4KB
inhibition in the replication-independent system. The results
closely resembled those obtained for CVB3 3A-H57Y cDNA
both with and without PI4KB inhibition (Figure 5B). This demon-
strates that the 3A-H57Y substitution does not affect Golgi
disintegration.
Altogether, these findings strongly suggest that enterovirus
RO biogenesis is driven by PI4KB activity.
The 3A-H57Y Substitution Rectifies a Proteolytic
Polyprotein Processing Impairment Induced by PI4KB
Inhibition
Another important step in the enterovirus replication cycle that
relies on membranes is the proteolytic processing of the poly-
protein by the viral proteases (Molla et al., 1993). Proteolytic
polyprotein processing is a co- and post-translational event
mediated by the viral proteinases 2Apro, 3Cpro, and 3CDpro.
These proteinases catalyze a cascade of cleavages in cis and
in trans that liberate individual capsid proteins, as well as repli-
cation proteins and their precursors (e.g., 2BC, 3AB, and 3CD).
Recent studies indicate that alterations to the lipid composition
of membranes during PV infection impact polyprotein process-
ing efficiency (Ilnytska et al., 2013; Ford Siltz et al., 2014; Arita,
2016). Given that WT virus replication is abolished under PI4KB
inhibition, we used the replication-independent CVB3 expres-
sion system to study the effects of PI4KB inhibition on polypro-
tein processing. Cells were lysed at 16 hpt and processed for
western blot analysis. PI4KB inhibition led to a relative accumu-
lation of 3AB and a reduction in 3A for the WT polyprotein (Fig-
ure 5C, left). Remarkably, the 3A-H57Y substitution rectified
this impaired polyprotein processing, as the relative levels of
3AB and 3A were not affected by PI4KB inhibition (Figure 5C,
right). PI4KB inhibition did not affect levels of 3CD or 3D.
Together, these results demonstrate that PI4KB activity is
important for proteolytic processing at the 3A-3B junction,
but not at the 3C-3D junction (or at the 2C-3A and 3B-3C junc-
tions). The 3A-H57Y substitution restores processing to the
level detected in the absence of inhibitor, which may point to
a potential strategy of the mutant virus to escape PI4KB
inhibition.
The Delay in RO Formation under PI4KB Inhibition Does
Not Elicit a Strong Antiviral Response
One of the proposed advantages of ROs is that they may shield
vRNA products against vRNA sensors present in the cytoplasm,
such as MDA5, RIG-I, and PKR. Given that CVB3 3A-H57Y is
able to replicate its genome at the Golgi apparatus under
PI4KB inhibition, vRNA products may be more accessible and
better detected in this situation, thereby triggering an antiviral
response that might limit or delay replication. To investigate
whether viral dsRNA is better sensed under PI4KB inhibition,
we studied the activation status of the cytoplasmic RNA sensor
PKR. Western blot analyses were performed on infected cell ly-
sates to assess viral protein levels in parallel with dsRNA-acti-
vated phosphorylated PKR (p-PKR). The first appearance and
the final levels of viral proteins were delayed and reduced
respectively under PI4KB inhibition, which is in agreement with
the observed reduction in the proportion of infected cells and
the decrease in viral protein per cell (Figure S2C). Nevertheless,
p-PKR emerged concomitantly with the accumulation of viral
proteins in both the presence and absence of PI4KB inhibitor
(Figure 6A), suggesting that delayed RO formation under
PI4KB inhibition does not lead to premature activation of PKR.
Another innate antiviral response that is activated upon
sensing of vRNA products is the IFN-a/b pathway. Enteroviruses
counteract the transcription of IFN-a/b genes by cleaving com-
ponents in the signaling pathways that control their activation,
such as MDA5 (Feng et al., 2014) and its downstream adaptor,
MAVS (Feng et al., 2014; Mukherjee et al., 2011). The altered
location of genome replication under PI4KB inhibition may influ-
ence the ability of the viral proteinases to cleave these compo-
nents. However, we found that the appearance of MAVS degra-
dation products in infected cell lysates coincided with the
accumulation of viral proteins irrespective of the presence of a
PI4KB inhibitor (Figure 6A). Furthermore, qPCR analysis showed
that no substantial IFN-b responsewas triggered in infected cells
in both conditions (Figure 6B). Together, these results indicate
that the delayed formation of ROs during infection does not
accelerate cellular sensing of viral dsRNA, nor does it affect
the ability of the viral proteinases to cleave MAVS.
As a complementary approach to investigate whether the
delay in replication in the presence of PI4KB inhibitor is related
to activation of innate antiviral responses, the level of CVB3
3A-H57Y replication was determined in cells lacking sensors of
these pathways. Knockout cells for PKR or MAVS, generated
with CRISPR-Cas9 technology, were infected with CVB3 WT
or 3A-H57Y that also encode Renilla luciferase as a sensitive
measure to quantify the level of viral replication. In the absence
of inhibitor, CVB3 3A-H57Y replicated to a similar extent in
HeLa, HeLa PKR/, or HeLa MAVS/ cells (Figures 6C and
S6). In the presence of PI4KB inhibitor, CVB3 3A-H57Y
replication was delayed not only in HeLa cells, but also in PKR/
or MAVS/ cells. Thus, replication under PI4KB inhibition
was not significantly increased in PKR/ or MAVS/ cells
compared to parental HeLa cells. Similar results were obtained
in U2OS cells, another human cell line (Figures S5A and S6).
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AB
C
Figure 5. Effect of PI4KB Inhibition on Enterovirus-
Induced Golgi Disintegration and Proteolytic Polyprotein
Processing in a Replication-Independent CVB3 System
HuH-7/T7 cells transfected with CVB3 3A-H57Y or WT CVB3
cDNA under the control of a T7 promoter, both rendered replica-
tion incompetent by altering the 50 UTR of the genome. Where
indicated, cells were treated with BF738735.
(A and B) Cells fixed at 4 hr or 5 hr post-transfection with CVB3 3A-
H57Y cDNA (A) or CVB3 WT cDNA (B) and labeled for 3A (green)
and GM130 (red) alongside a nuclear stain (blue). Representative
3A-positive cells are indicated (arrowheads). Scale bars represent
20 mm.
(C) Western blot analysis of lysates from cells at 16 hr post-
transfection using antibodies against 3A or 3D. Actin was used as a
loading control.
See also Figure S4.
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Figure 6. Innate Antiviral Responses during CVB3 3A-H57Y Infection
Cells infected and treated with BF738735 where indicated.
(A) HeLa cells infected with CVB3 3A-H57Y (MOI 50) were lysed for western blot analysis at the indicated time points. Band sizes (in kilodaltons), full-length
proteins (arrows), and putative cleavage products (arrowheads) are indicated.
(B) HeLa cells infected with CVB3 WT or CVB3 3A-H57Y (MOI 10). Total RNA was isolated from cells and subjected to qRT-PCR for interferon-b (IFN-b). Mengo
Zn, whose L protein contains substitutions that render it unable to suppress IFN-b induction, was included as a positive control (left graph). vRNA levels were
(legend continued on next page)
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An alternative strategy employed by some eukaryotes, such
as plants, worms, and insects, in response to viral infections
is RNAi, although whether RNAi is an antiviral mechanism in
mammalian cells remains controversial (Luna et al., 2016). In
the RNAi pathway, the cytoplasmic sensor Dicer cleaves viral
dsRNA into viral small interfering RNAs (siRNAs), which are
loaded by Argonaute-2 (AGO2) into the RNA-induced silencing
complex (RISC) in order to degrade vRNA (tenOever, 2016).
Recently, it was reported that replication of the picornavirus
EMCV was enhanced in mammalian somatic cells that lacked
AGO2 (Li et al., 2016). To investigate whether the delay in
CVB3 3A-H57Y replication in the presence of PI4KB inhibitor is
due to triggering of antiviral RNAi, we studied its replication
kinetics in HeLa and HEK293T cells that lacked AGO2. Similar
to our findings in MAVS and PKR knockout cell lines, the delay
in replication under PI4KB inhibition was not alleviated in cells
lacking AGO2 (Figures 6D and S5B).
Altogether, these data suggest that the delay in CVB3 3A-
H57Y replication under PI4KB inhibition is not caused by prema-
ture triggering of innate antiviral responses as result of impaired
RO biogenesis.
DISCUSSION
Like all other +RNA viruses infecting eukaryotes, enteroviruses
modify host cell endomembranes to form structures with novel
morphologies (ROs) dedicated to amplification of the viral
genome. Enteroviruses hijack host factors and modulate lipid
synthesis and homeostasis pathways to build ROs with a unique
protein and lipid signature (van der Schaar et al., 2016a; Strating
and van Kuppeveld, 2017). One of the lipid-modifying host fac-
tors previously shown to be essential for enterovirus genome
replication is PI4KB (Hsu et al., 2010; van der Schaar et al.,
2013). In this study, we clarify the role of PI4KB and the PI4P-
enriched environment it generates in CVB3-infected cells by
establishing its importance for proteolytic processing of the pol-
yprotein and RO biogenesis. To do so, we exploited the CVB3
3A-H57Y mutant (van der Schaar et al., 2012), which is able to
establish replication under PI4KB inhibition, albeit with a delay.
CVB3 3A-H57Y generated ROs in a manner identical to WT
CVB3 in the absence of the PI4KB inhibitor. Strikingly, under
PI4KB inhibition, ROs were not observed during the peak hours
of vRNA synthesis. Instead, vRNA synthesis was detected at the
Golgi apparatus. Utilizing a replication-independent expression
system, we ascertained that the impairment in RO formation
was a consequence of PI4KB inhibition and not merely the result
of delayed replication. Together, these findings demonstrate that
PI4KB activity drives rapid RO formation.
In the absence of ROs, seemingly intact Golgi membranes are
sufficient to facilitate vRNA replication of the mutant virus. Thus,
the Golgi apparatusmight also support initial genome replication
duringWT virus infection, prior to RO formation. The detection of
CVB3 vRNA at the Golgi apparatus by fluorescence in situ hy-
bridization early in infection (Hsu et al., 2010), while not directly
proving RNA synthesis, would support this possibility. However,
the Golgi apparatus is rapidly disassembled to form ROs during
uninhibitedWT CVB3 infections (Hsu et al., 2010; van der Schaar
et al., 2016b), while during 3A-H57Y mutant infections, under
PI4KB inhibition, this phase of replication at the Golgi apparatus
was markedly prolonged, encompassing the exponential phase
of genome replication. This illustrates a remarkable flexibility
in the use of membranes as a platform for genome replication
and contributes to the idea that +RNA-virus-induced membrane
modification may be an adaptable process. Previous studies
have reported that for some +RNA viruses, like tombusviruses
and nodaviruses, replication can even be shifted to a different
cellular organelle (Xu and Nagy, 2014). It is unknown whether
these adoptive membranes are still remodeled to form ROs in
all cases. Our findings also align with studies that show a rela-
tionship between RO formation and PI4P for viruses that depend
on the activity of PI4KA (phosphatidylinositol 4-kinase type IIIa).
When PI4KA is depleted or inhibited, HCV and EMCVwere found
to exhibit atypical RO development, as evidenced by clustering
of ROs (Reghellin et al., 2014; Dorobantu et al., 2016) or altered
RO morphology (Reiss et al., 2011), pointing to a central role
for PI4P-producing kinases in RO biogenesis for these viruses
as well.
PI4KB inhibition did not ultimately prevent the development of
enterovirus ROs, which were readily detected at the late stages
of CVB3 3A-H57Y infection. Immunofluorescence microscopy
revealed that these late stages of infection were not associated
with an accumulation of PI4P. Thus, despite the role of active
PI4KB in facilitating rapid RO biogenesis in uninhibited infec-
tions, PI4P is not a strict requirement for their formation. What
then is the role of PI4P in RO biogenesis? One possibility is
that PI4P serves to recruit cholesterol, a lipid that significantly af-
fects membrane structure and function. Cholesterol has been
shown to accumulate at ROs (Ilnytska et al., 2013; Roulin et al.,
2014; Strating et al., 2015; Arita, 2014) and may be involved in
their formation. Recent evidence suggests that during WT
enterovirus infection, cholesterol is trafficked to ROs via two
PI4KB-dependentmechanisms. One of these is the PI4P-depen-
dent exchange of cholesterol via OSBP (Albulescu et al., 2015;
Strating et al., 2015). The second relies on the physical interac-
tion between PI4KB and Rab11 on recycling endosomes, which
can divert endosomal cholesterol to ROs (Ilnytska et al., 2013;
Burke et al., 2014). PI4KB inhibitors limit PI4P accumulation
and will thus limit OSBP-mediated cholesterol transfer. How-
ever, enzymatically inactive PI4KB may retain its ability to
interact with Rab11 (de Graaf et al., 2004) and CVB3 3A-H57Y
could in this way recruit sufficient cholesterol for (delayed) RO
formation under PIK4B inhibition.
How can the acquisition of a single point mutation in the 3A
protein allow enteroviruses to overcome their dependence on
determined by qRT-PCR (right graph). Data were normalized to actin mRNA levels. Results are expressed as fold induction relative to quantities in mock-infected
cells. Two independent experiments are shown, ranging from 2 to 8 hpi and 8 to 12 hpi.
(C and D) HeLa, HeLa PKR, and MAVS knockout (C) or HeLa AGO knockout (D) cells were infected with CVB3-Rluc 3A-H57Y (MOI 0.01) and lysed to determine
intracellular luciferase levels. Values represent mean values of triplicates ± SEM.
See also Figures S5 and S6.
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a critical host factor like PI4KB? Recent studies have indicated
that the lipid composition of membranes is an important determi-
nant for efficient proteolytic processing of the PV polyprotein and
that PI4KB inhibition can perturb cleavage at specific junctions
(Ilnytska et al., 2013; Ford Siltz et al., 2014; Arita, 2016). For
WT CVB3 cDNA, we observed that 3AB accumulated and 3A
levels were reduced under PI4KB inhibition, while levels of other
viral proteins were unaffected. This suggests that PI4P facilitates
processing specifically at the 3A-3B junction. Importantly, the
3A-H57Y substitution rendered polyprotein processing indepen-
dent of high levels of PI4P lipids, as normal levels of precursor
and products were detected under PI4KB inhibition. Restoring
polyprotein processing efficiency may be a general resistance
mechanism of enteroviruses to overcome PI4KB inhibition. The
PV 3A-A70T substitution, which confers resistance to PI4KB in-
hibitors, in PV also restored a cleavage defect at the 3A-3B junc-
tion in the presence of PI4KB inhibitors (Arita, 2016). Notably, the
H57Y substitution in CVB3 3A andA70T in PV 3A are respectively
close to or present in the C-terminal hydrophobic domain. It is
possible that these substitutions near or in themembrane anchor
of 3A impose an altered conformation to 3AB that increases
the accessibility of the 3AB cleavage site in the absence of
high PI4P levels.
Why is the replication efficiency of CVB3 3A-H57Y lower under
PI4KB inhibition? If enterovirus ROs enhance viral replication by
expanding the membrane surface available for vRNA synthesis,
it may be that impaired RO biogenesis in the absence of PI4KB
activity directly limits replication. The formation of ROs might
also contribute to host immune response evasion, leading to a
higher replication efficiency. The disassembly of the secretory
pathway, which occurs in conjunction with RO formation, has
been suggested to limit cytokine secretion and downregulate
major histocompatibility complex class I (MHC class I) surface
expression (Dodd et al., 2001; Cornell et al., 2007), thereby cur-
tailing activation of the adaptive immune system. ROsmay serve
as a barrier to activation of the innate immune system by physi-
cally segregating viral products and cellular sensors, such as
RIG-I, MDA5, and PKR. This strategy is employed by HCV, which
limits access of RIG-I and MDA5 to their ROs by diverting
components of the nuclear transport machinery (Neufeldt et al.,
2016). Some +RNA viruses, such as DENV (Welsch et al., 2009)
or Zika virus (Cortese et al., 2017), induce negative membrane
curvature to form invaginations in the boundary membranes
of organelles, in which genome replication takes place. These
invagination-type compartments have small pores toward the
cytoplasm for selective import/export of material, which is pro-
posed to restrict access of cellular RNA sensors. Enteroviruses,
however, induce positive membrane curvature to generate ROs
that protrude into the cytosol. Given that genome replication
takes place on the cytosolic surface of membranes, enterovirus
vRNA products may be more exposed and thus more vulnerable
to cellular sensors. Early work with PV showed that ‘‘rosettes of
virus-induced vesicles’’ isolated from infectedcells providedpro-
tection against RNase-treatment in vitro (Bienz et al., 1992), but
whether ROs in infected cells also protect vRNA from RNase
treatment is unknown. In our study, we found no signs of prema-
ture sensing of viral dsRNAbyPKRunder PI4KB inhibition, a con-
dition where RO formation was found to be delayed and replica-
tion occurred at a seemingly intactGolgi apparatus. Consistently,
the delay in CVB3 3A-H57Y replication under PI4KB inhibition
was not alleviated in PKR/ cells. Furthermore, replication of
CVB3 3A-H57Y was not enhanced in MAVS/ cells, which are
defective in signaling induced byMDA5 andRIG-I, or in AGO2/
cells in which the Dicer-dependent RNAi pathway is rendered
non-functional. Together, these findings challenge the idea that
enterovirus ROs have a critical function in shielding viral dsRNA
from cellular RNA sensors. Enteroviruses have acquired other
mechanisms to suppress innate immune responses that rely on
the cleavage of essential signaling pathway components (such
as MDA5, MAVS, and the integral stress response protein
G3BP1) by their proteinases (Lei et al., 2016). However, the
possibility remains that ROs serve as a redundant protective
measure against innate immune sensors, perhaps with a more
prominent role in other cell types than those used here.
The pervasiveness of virus-induced membrane modifications
across the Picornaviridae and other viral families suggests that
theyprovidean inherentbenefit to+RNAvirus replication,perhaps
by facilitating efficient vRNA synthesis or by coordinating different
events in the viral life cycle. Through further investigations using
drug-resistant viruses, replication-independent viral systems or
other novel approaches, the intrinsic benefits of thesemorpholog-
ically diverse replication compartments will be unveiled.
EXPERIMENTAL PROCEDURES
Replication-Independent System
HuH-7/T7 cells were seeded in 24-well plates containing glass coverslips. The
next day, the cells were lipofectamine transfected with CVB3 cDNA rendered
replication deficient through modifications to the cloverleaf structure in the
50 UTR of the viral genome (Langereis et al., 2014). 1 hr later, the medium
was replaced with fresh medium. At indicated hours post-transfection, cells
were washed and either fixed for immunofluorescence or lysed for western
blot analysis.
Live-Cell Imaging
BGM(GFPS1-10) cells were grown in glass-bottom 4-chamber 35-mm dishes
(CELLview) to 35% confluency and transduced with MLV mCherry-GM130
particles described previously (van der Schaar et al., 2016b). Infection with
CVB3 3A-H57Y(S11) was carried out 18–24 hr later. Prior to imaging, cells
were washed with Fluorobrite medium (Thermo Fisher Scientific) supple-
mented with 8% fetal calf serum (FCS) and 25 mM HEPES. Cells were main-
tained in a live-cell imaging chamber at 37C and 5% CO2. Imaging was
carried out from 2.5 hpi using a Leica SP5 confocal microscope. Positions
of interest (xyz) were marked and imaged sequentially at 5-min intervals.
High-Pressure Freezing and Freeze Substitution
BGM cells were grown on sapphire discs and infected with CVB3 or CVB3 3A-
H57Y and refreshed at 1 hpi with medium supplemented with 25 mM HEPES
buffer with or without 1 mm BF738735. Cells were high-pressure frozen using
a Leica EM PACT2 at different time points post-infection. The instruments
and procedures used for freeze substitution, epoxy resin infiltration, and poly-
merization were identical to those described previously (Limpens et al., 2011).
Sections of 70 nm were then prepared for EM and post-stained with uranyl
acetate and lead citrate.
CLEM Preparation
BGM (GFPS1-10) cells were cultured in gridded 8-well chamber m-slides (Ibidi)
ahead of infection with CVB3 3A-H57Y(S11). Just prior to imaging, cells were
treated with 100 nM Mitotracker Deep Red FM for 30 min. Live-cell imaging
was carried out to monitor the levels of 3A-H57Y-GFP. High-resolution
(1,0243 1,024) z stacks were collected of cells of interest just prior to fixation.
Cell Reports 21, 587–599, October 17, 2017 597
To aid in the relocation of these cells for CLEM, tile scan overviews were taken
and the positions of cells relative to nearby grid co-ordinates were recorded.
Following imaging by live-cell light microscopy (LM), cells were prepared
for EM as described previously (van der Schaar et al., 2016b). EM images
were collected of cells previously identified by LM. The EM and LM data
for each cell were overlaid using the Mitotracker Deep Red FM signal (LM
images) and corresponding mitochondria (EM images) as a guide for image
transformation.
Metabolic Labeling and Autoradiography
A subconfluent layer of BGM cells was grown in 35-mm dishes (Corning Life
Sciences) and infected with CVB3 or CVB3 3A-H57Y atMOI 5. Cells were incu-
bated with dactinomycin for 1 hr prior to a 45 min labeling with tritiated uridine
([5-3H], 1 mCi/mL) (Perkin Elmer). Cells were processed for EM as described
previously (van der Schaar et al., 2016b). 50-nm sections of were collected,
post-stained with lead citrate and uranyl acetate, and then prepared for auto-
radiography as described previously (Ginsel et al., 1979).
EM
Images were collected on an FEI Tecnai12 BioTWIN or TWIN electron micro-
scope at 120 kV using an Eagle 4k slow-scan CCD camera (FEI) or OneView
4k high-frame-rate camera (Gatan), respectively. For the collection of larger
EM datasets, meshes of overlapping areas across the grid were taken and
then later stitched into a single composite image as described previously
(Faas et al., 2012).
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